Goldline Pharmaceutical IPO Allotment Status

Check Goldline Pharmaceutical Allotment Status by PAN

Check Goldline Pharmaceutical allotment result online using PAN card. Registrar: Bigshare Services Pvt. Ltd. | Allotment Date: 15 May 2026

Not getting a result here? You can also check Goldline Pharmaceutical allotment directly on the Bigshare Services portal →

Goldline Pharmaceutical IPO — Allotment & Listing Timeline

IPO Open12 May 2026
IPO Close14 May 2026
Basis of Allotment15 May 2026
Refund Initiation18 May 2026
Listing Date19 May 2026
Issue Price₹41–43
Issue Size₹12.00 Cr
IPO TypeSME
Listing AtBSE
RegistrarBigshare Services Pvt. Ltd.
Listing Price₹59.75
Listing Gain+38.95%

Goldline Pharmaceutical IPO — Subscription & Allotment Odds

Based on the latest subscription figures for Goldline Pharmaceutical IPO (overall 840.57x subscribed). The more a category is oversubscribed, the lower each applicant's chance of allotment.

Retail 0.13% (880.68x)
Low chance
S-HNI 0.06% (1,662.35x)
Low chance
B-HNI 0.30% (1,662.35x)
Low chance

In the Retail category, roughly 1 out of every 100 applicants would get an allotment in Goldline Pharmaceutical IPO (lottery at one lot). Applying for more than one lot does not improve retail odds.

How to Check Goldline Pharmaceutical Allotment Status

  1. Enter your PAN card number (10-character alphanumeric) in the field above.
  2. Click "Check Status" to query the registrar.
  3. View your Goldline Pharmaceutical allotment result instantly — shares applied, allotted, and refund details.

The Goldline Pharmaceutical allotment check is processed through Bigshare Services Pvt. Ltd., the official registrar for Goldline Pharmaceutical IPO. You can check Goldline Pharmaceutical allotment status any time after the allotment date using your PAN.

Goldline Pharmaceutical IPO Allotment Process

Once the Goldline Pharmaceutical IPO subscription window closes, Bigshare Services Pvt. Ltd. processes all valid bids and finalizes the allotment on T+1 — the working day after the issue closes — with the shares listing on T+3 under SEBI's listing timeline. The Basis of Allotment is then published on the registrar's website.

How the draw of lots works for each category, and when shares and refunds reach you, are the same for every issue — see IPO Allotment Process Explained.

You can check your Goldline Pharmaceutical allotment status above using your PAN — the same PAN you used while applying. See all recent IPO allotment results or estimate allotment chances. Last updated: 15 May 2026, 07:38 pm IST.

Goldline Pharmaceutical Allotment FAQs

Enter your 10-character PAN number on this page and click Check Status. The page queries Bigshare Services Pvt. Ltd. and shows your Goldline Pharmaceutical IPO allotment result instantly — shares applied, shares allotted, and the amount adjusted or refunded.

The registrar for Goldline Pharmaceutical IPO is Bigshare Services Pvt. Ltd.. They process the Goldline Pharmaceutical allotment, maintain records of shares allotted to each applicant, and handle refunds for unallotted applications.

The Goldline Pharmaceutical IPO allotment date was 15 May 2026. You can check your Goldline Pharmaceutical allotment result using PAN above.

The funds blocked under your ASBA / UPI mandate are released within 1–2 working days of the allotment date — for Goldline Pharmaceutical that is 15 May 2026, so expect the block to lift by around 17 May 2026. No fees are charged; the money simply becomes available again. With Goldline Pharmaceutical retail subscribed 880.68x, roughly 100% of retail applicants are expected to go unallotted.

Allotted Goldline Pharmaceutical shares are credited to your Demat account 1 working day before listing (T−1) — Goldline Pharmaceutical lists on 19 May 2026, so the credit should appear on or just before 18 May 2026. Verify it in your Demat statement before listing day.

No. PAN is mandatory to check IPO allotment status. Most registrars also support checking by Application Number or Demat (DP ID + Client ID) — visit the Bigshare Services Pvt. Ltd. portal directly using the link above for those options.

Goldline Pharmaceutical was subscribed 840.57x overall, and each oversubscribed category is allotted by draw of lots at its minimum lot. On those figures the per-category odds work out as:
  • Retail — subscribed 880.68x, about 0.1% chance of allotment
  • S-HNI — subscribed 1,662.35x, about 0.1% chance of allotment
  • B-HNI — subscribed 1,662.35x, about 0.3% chance of allotment

QIB is allotted proportionately rather than by lottery, so it is not listed above. The Basis of Allotment document on Bigshare Services Pvt. Ltd.'s website carries the final figures.

← Goldline Pharmaceutical IPO Details View All IPO Allotments
GMP Update